Hong Kong Baptist University
hkbu.edu.hkTotal trials
78
Active
12
Phase 3
1
Total enrollment
36,980
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Chinese herbal medicine formula | — | — | — | — | — | 1 | |
| Chinese Herbal Medicine granules | — | — | — | — | — | 1 | |
| SCD-2101 | — | — | — | — | — | 1 |
Next readouts
- 2024-09
- 2024-11-15
- 2026-03-15
Top conditions
- Physical Activity6
- Sleep3
- Functional Constipation3
- Constipation3
- Obesity3
- Electro-acupuncture2
- Gastrointestinal Disorders2
- Irritable Bowel Syndrome2
Frequently asked questions about Hong Kong Baptist University
- How many clinical trials does Hong Kong Baptist University have on ClinicalTrials.gov?
- Hong Kong Baptist University is listed as the lead sponsor on 78 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hong Kong Baptist University's trials are in Phase 3?
- 1 of Hong Kong Baptist University's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Hong Kong Baptist University focus on?
- Hong Kong Baptist University's most-studied conditions on ClinicalTrials.gov are Physical Activity, Sleep, Functional Constipation, Constipation, Obesity.
- When are Hong Kong Baptist University's next clinical trial readouts?
- Hong Kong Baptist University has 3 upcoming primary-completion readouts tracked here; the soonest is “CHM for T2DM & MetS”, expected around 2024-09.